Drug intelligence / Profile preview

technetium (99mTc) albumin nanocolloid

Development stage
Unknown
Lead developer
GE Healthcare
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Subcutaneous, Intradermal, Peritumoral, Interstitial
01

Overview

Technetium (99mTc) albumin nanocolloid (marketed as Nanocoll) is a radiopharmaceutical imaging agent consisting of human serum albumin nanocolloids radiolabeled with the gamma-emitting isotope technetium-99m. The particles range in size from 5 to 80 nm, a specification that optimizes their transport through the lymphatic system. Following peritumoral, intradermal, or subcutaneous injection, the nanocolloid particles are drained by lymphatic vessels and sequestered by macrophages and histiomonocytic cells within the sentinel lymph nodes. This mechanism enables preoperative scintigraphic imaging and intraoperative localization using a gamma probe, primarily for sentinel lymph node mapping in breast cancer and melanoma. It is also utilized for bone marrow scintigraphy and the imaging of inflammatory processes.

Brand names
Nanocoll
Other names
technetium-99m nanocolloidal albumintechnetium99m nanocolloidal albumintechnetium 99m nanocolloidal albumin99mTc-Nanocoll99mTc-albumin nanocolloidTc-99m nanocolloidTc99m nanocolloidTc 99m nanocolloidtechnetium-99m nanocolloidtechnetium99m nanocolloidtechnetium 99m nanocolloid

Beyond the preview

Go deeper on technetium (99mTc) albumin nanocolloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium (99mTc) albumin nanocolloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call